OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-ELOVL5 antibodies
UltraMAB

Anti-ELOVL5 GAT Antibody Polyclonal

Generated by Genomic Immunization

div

Specifications Citations Related Products Product Documents
SKU Description Amount Price Availability*  
TA590466
  • Rabbit Polyclonal ELOVL5 Antibody
100ug 325 In Stock
Add to Shopping Cart
WB(1)
IHC(1)
spacer
Also for ELOVL5 (NM_021814)
cDNA Clone shRNA/siRNA Lysate Protein Request Antibody

OriGene Data

ImmunogenDNA immunization. This antibody is specific for the C Terminus Region of the target protein.
Clone NamePolyclonal IsotypeIgG
Species ReactivityHuman Concentration1.17mg/ml
Guaranteed Application *WB, IHC Suggested DilutionsWB: 1:5000-1:20000; ELISA: 1:100-1:2000; IHC: 1:10-1:2000; IHC-P 1:10-1:2000
Buffer20 mM Potassium Phosphate, 150 mM Sodium Chloride, pH 7.0
Purification The fragment used for DNA immunization was expressed in E.coli and the purified protein fragment was used for affinity purification of the antibody.
Note This antibody was generated by SDIX's Genomic Antibody Technology ® (GAT). Learn about GAT

Reference Data

Target NameHomo sapiens ELOVL fatty acid elongase 5 (ELOVL5), transcript variant 1
Alternative NamedJ483K16.1; HELO1; SCA38
Database LinkNP_068586
Entrez Gene 60481 Human
FunctionELOVL5 plays a role in elongation of long-chain polyunsaturated fatty acids (Leonard et al., 2000)
Related PathwayTransmembrane Biosynthesis of unsaturated fatty acids

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

WB Image
Western Blot: ELOVL5 Antibody - Samples: Lane 1, Marker: 250, 130, 95, 72, 55, 36, 28, 17, 11 Lane 2, RT-4 Lane 3, U-251MG sp Lane 4, Human Plasma Lane 5, Liver Lane 6, Tonsil , Target weight: 35, 10 (splice variants) Validation score: 2 Validation description: Supportive - Band of predicted size in kDa (+/-20%) with additional bands present.
IHC Image
Immunohistochemistry: ELOVL5 Antibody - Most normal and malignant tissues exhibited moderate cytoplasmic and/or nuclear immunoreactivity. Strong staining was for example observed in Leydig cells, the prostate, seminal vesicles and most parts of the intestine. Some tumor types displayed strong immunoreactivity e.g. breast, colo-rectal and lung cancers. In contrast to the normal bile duct cells, which were negative, showed the cholangiocarcinomas generally moderate cytoplasmic staining. The renal cancers and most malignant lymphomas were weakly stained or negative. Image and statement courtesy of the Human Protein Atlas (HPA).

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title